Massimo Costantini

Azienda Unità Sanitaria Locale Della Romagna

Papers

1

Total Citations

27

H-Index

1

About

Massimo Costantini is a leading figure in head and neck surgical oncology, with a primary focus on the application and outcomes of trans-oral robotic surgery (TORS) for oropharyngeal carcinomas. His most cited work, a landmark 9-year institutional experience published in 2019 (27 citations), provides critical long-term data on the surgical and oncologic outcomes of patients treated with TORS for oropharyngeal squamous cell carcinomas (OPSCC). This study has been instrumental in demonstrating the efficacy and safety of TORS, both with and without adjuvant therapy, helping to establish it as a standard-of-care approach. Costantini’s research directly addresses the paradigm shift from open, morbid procedures to minimally invasive robotic techniques, significantly impacting patient recovery and quality of life. His contributions have helped define modern surgical protocols and patient selection criteria for OPSCC, influencing clinical practice worldwide. Through his rigorous outcomes analysis, Costantini has solidified TORS’s role in the multidisciplinary management of head and neck cancers, making him a key authority in robotic head and neck surgery.

Research Focus

Key Achievements

1
H-Index
1
Papers
27
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Trans-oral robotic surgery for the management of oropharyngeal carcinomas: a 9-year institutional experience
27 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Azienda Unità Sanitaria Locale Della Romagna

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 10 days ago